VN · Healthcare

DHG Pharmaceutical JSC (DHG)

Drug Manufacturers - Specialty & Generic

DHG Pharmaceutical JSC (DHG) is listed on VN in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DHG

P/E ratio

18.00

DHG Pharmaceutical JSC (DHG) — FAQ

What is DHG's P/E ratio?

The price-to-earnings (P/E) ratio for DHG Pharmaceutical JSC (DHG) is 18.00 (data as of 2026-05-24).

Does DHG Pharmaceutical JSC pay a dividend?

Dividend yield is not available in the current snapshot for DHG Pharmaceutical JSC (DHG). Check the MyAverix Finance app for the latest dividend data.

What sector is DHG Pharmaceutical JSC in?

DHG Pharmaceutical JSC (DHG) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is DHG listed on?

DHG is listed on VN.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)